How a joined-up development strategy pays off for early-stage biotechs
Parexel Biotech’s Nate Akers and Vicky Hsu discuss how important it is for biotechs to align clinical execution with a clearly defined regulatory strategy to increase the chance of success for a new drug program.
Related Insights
Blog
Overcoming risks in Phase 3 trials to accelerate time to market
Jan 22, 2025
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Video
Part 3: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Blog
Proof of product safety and efficacy: how to move ahead successfully in Phase 2 clinical development
Jan 22, 2025
Article
Australia: The Regulatory and Reimbursement Environment
Aug 28, 2023
Webinar
Regulatory roadmap for biotechs: Effective strategies for streamlined early phase development
May 6, 2025
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Article
Expedited Pathways Comparisons - US EU CHN
Oct 19, 2021
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Related Insights
Blog
Overcoming risks in Phase 3 trials to accelerate time to market
Jan 22, 2025
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Video
Part 3: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Blog
Proof of product safety and efficacy: how to move ahead successfully in Phase 2 clinical development
Jan 22, 2025
Article
Australia: The Regulatory and Reimbursement Environment
Aug 28, 2023
Webinar
Regulatory roadmap for biotechs: Effective strategies for streamlined early phase development
May 6, 2025
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Article
Expedited Pathways Comparisons - US EU CHN
Oct 19, 2021
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023